Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
NeoGenomics Inc (NeoGenomics) is a cancer diagnostics and pharma company that offers diagnostic, prognostic and predictive testing services. The company offers services including diagnostic services, biopharma services, oncology data solutions, regulatory support, tech-only services and consultative services. Its biopharma services include lab services, cell therapy solutions, antibody-drug conjugates (ADCs) solutions and biomarker solutions. NeoGenomics diagnostic services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, immunohistochemistry and digital imaging, molecular testing and morphologic analysis. The company’s therapy area incudes lung cancer, breast cancer, colorectal cancer, gastric cancer, gynecologic cancer and hematologic cancer. NeoGenomics is headquartered in Fort Myers, Florida, the US.
Headquarters
United States of America
Address
9490 Neogenomics Way, Fort Myers, Florida, 33912
Website
neogenomics.com
Telephone
1 239 7680600
No of Employees
2,500
Industry
Medical Equipment
Ticker Symbol & Exchange
NEO (NASD)
Revenue (2025)
$727.3M
10.1%
(2025 vs 2024)
EPS
XYZ
Net Income (2025)
XYZ
-37.2%
(2025 vs 2024)
Market Cap*
$1.2B
Net Profit Margin (2025)
XYZ
-24.6%
(2025 vs 2024)
* As of and is in US$
NeoGenomics Inc premium industry data and analytics
Products and Services
| Services | Brands |
|---|---|
| Oncology Data Solutions | HemeFISH |
| Regulatory Support | Paletrra |
| Consultative Services | PanTracer |
| XYZ | |
| XYZ | |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Contracts/Agreements | In July, the company along with France Tissue Bank signed an agreement with Owkin to create the first foundation model exclusively trained on immunohistochemistry images. |
| 2025 | New Products/Services | In May, the company introduced c-MET CDx, its c-MET companion diagnostic immunohistochemistry assay. |
| 2025 | Acquisitions/Mergers/Takeovers | In March, the company acquired Pathline LLC, a CLIA/CAP/NYS-certified laboratory. |
Competitor Comparison
| Key Parameters | NeoGenomics Inc | Quest Diagnostics Inc | Exact Sciences Corp | Natera Inc | Tempus AI Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Fort Myers | Secaucus | Madison | Austin | Chicago |
| State/Province | Florida | New Jersey | Wisconsin | Texas | Illinois |
| No. of Employees | 2,500 | 46,000 | 7,100 | 6,135 | 3,800 |
| Entity Type | Public | Public | Private | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Anthony P. Zook | Chief Executive Officer; Director | Executive Board | 2025 | 64 |
| Jeffrey S. Sherman | Chief Financial Officer | Senior Management | 2022 | 59 |
| Warren C. Stone | President; Chief Operating Officer | Senior Management | 2025 | 52 |
| Greg D. Aunan | Chief Accounting Officer | Senior Management | 2023 | 55 |
| Hutan Hashemi | Chief Compliance Officer | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer